The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems
Open accessPublished version of a preprint
Abstract
OBJECTIVE: Individuals at high risk for schizophrenia may benefit from early intervention, but few validated risk predictors are available. Genetic profiling is one approach to risk stratification that has been extensively validated in research cohorts. The authors sought to test the utility of this approach in clinical settings and to evaluate the broader health consequences of high genetic risk for schizophrenia. METHODS: The authors used electronic health records for 106,160 patients from four health care systems to evaluate the penetrance and pleiotropy of genetic risk for schizophrenia. Polygenic risk scores (PRSs) for schizophrenia were calculated from summary statistics and tested for association with 1,359 disease categories, including schizophrenia and psychosis, in phenome-wide association studies. Effects were combined through meta-analysis across sites. RESULTS: PRSs were robustly associated with schizophrenia (odds ratio per standard deviation increase in PRS, 1.55; 95% CI=1.4, 1.7), and patients in the highest risk decile of the PRS distribution had up to 4.6-fold higher odds of schizophrenia compared with those in the bottom decile (95% CI=2.9, 7.3). PRSs were also positively associated with other phenotypes, including anxiety, mood, substance use, neurological, and personality disorders, as well as suicidal behavior, memory loss, and urinary syndromes; they were inversely related to obesity. CONCLUSIONS: The study demonstrates that an available measure of genetic risk for schizophrenia is robustly associated with schizophrenia in health care settings and has pleiotropic effects on related psychiatric disorders as well as other medical syndromes. The results provide an initial indication of the opportunities and limitations that may arise with the future application of PRS testing in health care systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · cited 1×
“0 (32)—similar to the observed risk for the top schizophrenia PRS decile here.”
BackgroundAn atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Walker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Khera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., Natarajan, P., Lander, E. S., Lubitz, S. A., Ellinor, P. T., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0183-z · Cited by 2,953 · cited 2×
“A recent study investigating the clinical utility of PRSs for several common nonpsychiatric diseases (13) found that these scores can identify a larger fraction of high-risk individuals than are identified by clinically validated monogenic mutations; the study authors call explicitly for evaluations of these scores in…”
BackgroundMethodThe global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013
Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J. W., Patel, V., & Silove, D. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu038 · Cited by 2,846 · cited 1×
“Globally, approximately 18% of individuals suffer from mental illness every year (3), and 44.”
BackgroundClinical use of current polygenic risk scores may exacerbate health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0379-x · Cited by 2,821
Current clinical use of polygenic scores will risk exacerbating health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2018) · doi:10.1101/441261 · Cited by 2,813 · cited 1×
“It is well known that PRSs calculated from genome-wide association studies (GWASs) performed primarily in one ancestry demonstrate poorer performance in other ancestries as a function of differing linkage disequilibrium (LD) structures with causal variants and lack of diversity on genotyping platforms (23, 24).”
BackgroundAnalysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924 · cited 2×
“Given the substantial heritability of many psychiatric disorders (9) and their polygenic architecture (10), there is increasing interest in using quantitative measures of genetic risk for risk stratification (11).”
BackgroundSelf-citationPolygenic prediction via Bayesian regression and continuous shrinkage priors
Ge, T., Chen, C.-Y., Ni, Y., Feng, Y.-C. A., & Smoller, J. W. (2019) · Nature Communications · doi:10.1038/s41467-019-09718-5 · Cited by 1,922 · cited 1×
“PRS-CS allows multivariate modeling of local LD patterns and is robust to diverse underlying genetic architectures, and thus can increase the accuracy of PRS over conventional approaches (26).”
BackgroundSelf-citationWang, P. S., Berglund, P., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.603 · Cited by 1,325
Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2018) · Science · doi:10.1126/science.aad6469 · Cited by 1,095
Self-citationAnalysis of polygenic risk score usage and performance in diverse human populations
Duncan, L., Shen, H., Gelaye, B., Meijsen, J., Ressler, K., Feldman, M., Peterson, R., & Domingue, B. (2019) · Nature Communications · doi:10.1038/s41467-019-11112-0 · Cited by 1,038 · cited 1×
“It is well known that PRSs calculated from genome-wide association studies (GWASs) performed primarily in one ancestry demonstrate poorer performance in other ancestries as a function of differing linkage disequilibrium (LD) structures with causal variants and lack of diversity on genotyping platforms (23, 24).”
BackgroundAn Individualized Risk Calculator for Research in Prodromal Psychosis
Cannon, T. D., Yu, C., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Heinssen, R., Jeffries, C. D., Mathalon, D. H., McGlashan, T. H., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15070890 · Cited by 574
Psychiatric genetics and the structure of psychopathology
Smoller, J. W., Andreassen, O. A., Edenberg, H. J., Faraone, S. V., Glatt, S. J., & Kendler, K. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-017-0010-4 · Cited by 398 · cited 1×
“Given the substantial heritability of many psychiatric disorders (9) and their polygenic architecture (10), there is increasing interest in using quantitative measures of genetic risk for risk stratification (11).”
BackgroundSelf-citationEvidence of a dimensional relationship between schizotypy and schizophrenia: A systematic review
Nelson, M. T., Seal, M. L., Pantelis, C., & Phillips, L. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.004 · Cited by 334
Wei, W.-Q., Teixeira, P. L., Mo, H., Cronin, R. M., Warner, J. L., & Denny, J. C. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv130 · Cited by 230 · cited 1×
“Individuals with two or more relevant ICD-9/10 codeswere consideredcase subjects, thosewithzero relevant codes were considered control subjects, and individuals with only one code were excluded (30).”
BackgroundPerlis, R. H., Iosifescu, D. V., Castro, V. M., Murphy, S. N., Gainer, V. S., Minnier, J., Cai, T., Goryachev, S., Zeng, Q., Gallagher, P. J., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711000997 · Cited by 193 · cited 1×
“Future work refining case and control definitions using natural language processing algorithms may improve the predictive performance of PRSs and other risk factors for clinically derived phenotypes (45, 46).”
BackgroundSelf-citation
Research works printed but not linked: 29
- 10.1038/s41537-017-0034-4 · DOI
- 10.1016/j.schres.2014.01.022 · DOI
- 10.1016/S0920-9964(01)00278-X · DOI · Paper page
- 10.1016/j.biopsych.2016.06.028 · DOI · Paper page
- 10.1016/j.biopsych.2018.04.007 · DOI
- 10.3389/fgene.2014.00184 · DOI
- 10.1038/gim.2013.72 · DOI · Paper page
- 10.1002/ajmg.b.32548 · DOI
- 10.1038/nrg3461 · DOI · Paper page
- 10.1038/gim.2015.187 · DOI · Paper page
- 10.7554/eLife.25060 · DOI
- 10.3390/jpm6010002 · DOI · Paper page
- 10.1016/j.jbi.2014.02.003 · DOI · Paper page
- Duncan L, bioRxiv
- Martin AR, bioRxiv
- 10.1093/bioinformatics/btu848 · DOI · Paper page
- Ge T, Nat Commun 2019; 10:1776
- 10.1371/journal.pone.0175508 · DOI · Paper page
- 10.1093/bioinformatics/btu197 · DOI · Paper page
- 10.1016/j.ajhg.2018.04.001 · DOI
- 10.1016/j.schres.2017.10.037 · DOI
- 10.1093/schbul/sbt122 · DOI
- 10.1177/0004867415569796 · DOI
- 10.1016/j.schres.2016.12.001 · DOI
- 10.4239/wjd.v8.i8.390 · DOI · Paper page
- 10.1017/S0033291718001812 · DOI
- 10.1038/ng.3951 · DOI · Paper page
- 10.1093/schbul/sbx174 · DOI
- 10.1176/appi.ajp.2014.14030423 · DOI
Cited by
Polygenic risk scores: from research tools to clinical instruments
Lewis, C. M., & Vassos, E. (2020) · Genome Medicine · doi:10.1186/s13073-020-00742-5 · Cited by 1,360
Jauhar, S., Johnstone, M., & McKenna, P. J. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01730-x · Cited by 996
Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Nutrients · doi:10.3390/nu15122749 · Cited by 804
Improving polygenic prediction in ancestrally diverse populations
Ruan, Y., Lin, Y.-F., Feng, Y.-C. A., Chen, C.-Y., Lam, M., Guo, Z., Initiatives, S. G. A., Ahn, Y. M., Akiyama, K., Arai, M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01054-7 · Cited by 707
Self-citationThe Polygenic Score Catalog as an open database for reproducibility and systematic evaluation
Lambert, S. A., Gil, L., Jupp, S., Ritchie, S. C., Xu, Y., Buniello, A., McMahon, A., Abraham, G., Chapman, M., Parkinson, H., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00783-5 · Cited by 705
Metadata
- Authors
- Zheutlin, A. B., Dennis, J., Karlsson Linnér, R., Moscati, A., Restrepo, N., Straub, P., Ruderfer, D., Castro, V. M., Chen, C.-Y., Ge, T., Huckins, L. M., Charney, A., Kirchner, H. L., Stahl, E. A., Chabris, C. F., Davis, L. K., & Smoller, J. W.
- Venue
- American Journal of Psychiatry
- Published
- 2019-10-01
- Volume
- 176
- Issue
- 10
- Pages
- 846-855
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2967343033
- Cited by
- 223
- References
- 21
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.